World's Best Scientists 2026 revealed!
Torsten Tonn

Torsten Tonn

D-Index & Metrics

Immunology

D-Index
63
Citations
19004
World Ranking
2989
National Ranking
200

Torsten Tonn publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Torsten Tonn sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 222 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Torsten Tonn D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Torsten Tonn sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Torsten Tonn is a researcher affiliated with TU Dresden in Germany, focusing on medical science with extensive work in infectious diseases, immunology, and oncology. Their research output includes studies on immune cell dynamics, viral infections, and immunotherapies.

The main fields of study for Torsten Tonn encompass Medicine, with subfields including Infectious Diseases, Immunology, Oncology, Genetics, and Molecular Biology. Their research explores complex interactions within the immune system and diseases affecting the blood and immune cells.

Key topics in their work cover:

  • CAR-T cell therapy research
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • Erythrocyte Function and Pathophysiology
  • T-cell and B-cell Immunology

Torsten Tonn has published in several specialized journals and publication venues, notably:

  • Cytotherapy
  • Neuro-Oncology
  • Frontiers in Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Transfusion Medicine and Hemotherapy

Frequent co-authors collaborating with Tonn include:

  • Jaap Jan Boelens
  • Rachele Ciccocioppo
  • Ekaterina Doubrovina
  • Miguel Forte
  • Jacques Galipeau

Notable recent publications feature studies on SARS-CoV-2 immunity, COVID-19 patient prognostics, and cancer immunotherapy:

  • "Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine" (2021) published in The Lancet Regional Health - Europe
  • "SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care" (2021) published in Nature Communications
  • "Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma" (2020) published in Journal of Virological Methods
  • "Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma" (2023) published in Neuro-Oncology
  • "SARS-CoV-2 Infects Red Blood Cell Progenitors and Dysregulates Hemoglobin and Iron Metabolism" (2022) published in Stem Cell Reviews and Reports

Best Publications

  • Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

    Volker Schächinger;Sandra Erbs;Albrecht Elsässer;Werner Haberbosch

  • Transcoronary transplantation of progenitor cells after myocardial infarction.

    Birgit Assmus;Jörg Honold;Volker Schächinger;Martina B Britten

  • Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper

    Thomas Lener;Mario Gimona;Ludwig Aigner;Verena Börger

  • Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction.

    Florian H. Seeger;Torsten Tonn;Nicola Krzossok;Andreas M. Zeiher

  • Treatment of patients with advanced cancer with the natural killer cell line NK-92

    Torsten Tonn;Torsten Tonn;Dirk Schwabe;Hans G. Klingemann;Sven Becker;Sven Becker

  • Clinical Outcome 2 Years After Intracoronary Administration of Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

    Birgit Assmus;Andreas Rolf;Sandra Erbs;Albrecht Elsässer

  • ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma

    Congcong Zhang;Michael C. Burger;Lukas Jennewein;Sabrina Genßler

  • NK-92: an ‘off-the-shelf therapeutic’ for adoptive natural killer cell-based cancer immunotherapy

    Garnet Suck;Marcus Odendahl;Paulina Nowakowska;Christian Seidl

  • Retargeting of natural killer–cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction

    Christoph Uherek;Torsten Tonn;Barbara Uherek;Sven Becker

  • Cellular immunotherapy of malignancies using the clonal natural killer cell line NK-92.

    Torsten Tonn;Sven Becker;Ruth Esser;Dirk Schwabe

  • Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor

    Kurt Schönfeld;Christiane Sahm;Congcong Zhang;Sonja Naundorf

  • Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA)

    Dirk H. Walter;Hans Krankenberg;Jörn O. Balzer;Christoph Kalka

  • Restoration of Microvascular Function in the Infarct-Related Artery by Intracoronary Transplantation of Bone Marrow Progenitor Cells in Patients With Acute Myocardial Infarction The Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) Trial

    Sandra Erbs;Axel Linke;Volker Schächinger;Birgit Assmus

  • Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation

    Anita Schmitt;Torsten Tonn;Dirk H. Busch;Goetz Ulrich Grigoleit

  • Transcoronary Transplantation of Functionally Competent BMCs Is Associated With a Decrease in Natriuretic Peptide Serum Levels and Improved Survival of Patients With Chronic Postinfarction Heart Failure: Results of the TOPCARE-CHD Registry

    Birgit Assmus;Ulrich Fischer-Rasokat;Jörg Honold;Florian H. Seeger

  • Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity.

    Congcong Zhang;Pranav Oberoi;Sarah Oelsner;Anja Waldmann

  • Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells

    Tina Müller;Christoph Uherek;Guitta Maki;Kai Uwe Chow

  • Characterization of Genetically Altered, Interleukin 2-Independent Natural Killer Cell Lines Suitable for Adoptive Cellular Immunotherapy

    Y.K. Tam;G. Maki;B. Miyagawa;B. Hennemann

  • Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.

    Julian Stumpf;Torsten Siepmann;Tom Lindner;Claudia Karger

  • CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies

    Annette Romanski;Christoph Uherek;Gesine Bug;Erhard Seifried

  • Applying extracellular vesicles based therapeutics in clinical trials

    Thomas Lener;Mario Gimona;Ludwig Aigner;Verena Börger

Frequent Co-Authors

Erhard Seifried
Erhard Seifried German Red Cross
Winfried S. Wels
Winfried S. Wels Goethe University Frankfurt
Andreas M. Zeiher
Andreas M. Zeiher Goethe University Frankfurt
Stefanie Dimmeler
Stefanie Dimmeler Goethe University Frankfurt
Halvard Bonig
Halvard Bonig Goethe University Frankfurt
Ulrike Koehl
Ulrike Koehl Leipzig University
Rainer Hambrecht
Rainer Hambrecht University of Lübeck
Roberto Corti
Roberto Corti University of Zurich
Christian W. Hamm
Christian W. Hamm University of Giessen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens multiple doors, especially when paired with strategic online programs that accelerate career growth in healthcare. For those interested in nursing roles, exploring an accelerated FNP program can fast-track your path to becoming a Family Nurse Practitioner, combining clinical expertise with immunology knowledge.

Additionally, if you are new to the nursing field, online nursing programs designed specifically for non-nurses provide a flexible route to enter the profession. These online nursing programs for non nurses focus on foundational skills while accommodating diverse backgrounds.

For those seeking a quicker entry point, enrolling in absn programs with high acceptance rates is a practical choice. These accelerated Bachelor of Science in Nursing programs minimize barriers to admission without sacrificing quality education, often integrating immunology courses relevant to patient care.

Moreover, certified practical nursing remains a vital healthcare role. Many choose accredited LPN programs easy to get into as an accessible step towards clinical practice, where a foundational understanding of immunology supports infection control and patient safety.

Best Scientists Citing Torsten Tonn

Trending Scientists

Recently Published Articles